LB Pharmaceuticals Market Risk Adjusted Performance
| LBRX Stock | | | 26.46 0.79 3.08% |
Observed values used to calculate the Market Risk Adjusted Performance technical indicator for LB Pharmaceuticals Common. Technical inputs may vary across markets and data providers.
LB Pharmaceuticals Common has current Market Risk Adjusted Performance of
-0.47.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.47 | |
| ER[a] | = | Expected return on investing in LB Pharmaceuticals |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
LB Pharmaceuticals Market Risk Adjusted Performance Peers Comparison
LBRX Market Risk Adjusted Performance Relative To Other Indicators
LB Pharmaceuticals Common is rated
below average in market risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.